Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IMP2/IGF2BP2 Antibody (OTI3F9), Alexa Fluor™ 594, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP271615AF594

Catalog No. NP27161A94


Only null left
Add to Cart

Description

Description

IMP2/IGF2BP2 Monoclonal specifically detects IMP2/IGF2BP2 in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

IMP2/IGF2BP2
Monoclonal
Alexa Fluor 594
50 mM sodium borate with 0.05% sodium azide
IGF2BP2
Full length recombinant protein of human IMP2/IGF2BP2 (NP_006333) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat, Canine, Monkey
IgG1
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI3F9
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
Hepatocellular carcinoma autoantigen p62, IGF-II mRNA-binding protein 2, IMP-2IGF2 mRNA-binding protein 2, IMP2VICKZ family member 2, insulin-like growth factor 2 mRNA binding protein 2, insulin-like growth factor 2 mRNA-binding protein 2, p62, VICKZ2
Mouse
Affinity Purified
Cancer, Chromatin Research, Immune System Diseases, Immunology, Transcription Factors and Regulators
10644.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.